Quantum BioPharma Ltd. has announced the appointment of Kevin Malone as an advisor to its Board of Directors, highlighting his extensive experience in wealth management and focus on combating ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce the appointment of Kevin Malone as an advisor to the Board of Directors. Mr ...

TORONTO - Quantum BioPharma Ltd. (NASDAQ: QNTM), a biopharmaceutical company with a market capitalization of $16.67 million, announced today the appointment of Kevin Malone as an advisor to its ...

Mr. Malone brings a vast wealth of successful stock trading experience, especially in manipulated companies, from his years of wealth management. About Mr. Kevin Malone Mr. Malone is a 2nd ...